Related Experiment Video
Updated: Jan 27, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
Cangrelor Bridging Within 6 Months of a Drug-Eluting Stent in a Patient for Emergency Cervical Spine Surgery: A Case
Tiffany Y Hu1, Sophie M Peeters2, Daniel T Nagasawa2
1From the Departments of Medicine.
Abstract:
The recommended duration of dual antiplatelet therapy after drug-eluting stent placement presents a dilemma for patients with recent stenting who require urgent or emergency noncardiac surgery. We present the case of a patient with recent drug-eluting stent placement (<6 months) on dual antiplatelet therapy who underwent successful emergency cervical spine surgery with antiplatelet therapy bridged using cangrelor, an intravenous P2Y12 inhibitor antiplatelet agent. Our experience illustrates the multidisciplinary approach to a patient with high thrombotic and bleeding risk who underwent neurosurgery off both aspirin and a P2Y12 inhibitor.
Related Concept Videos
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Wheatstone Bridge
Thus, for accurate resistance measurements, a...
Emerging Adulthood

